RootPath Genomics: Funding, Investors & Team (Oct 2026)
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
RootPath Genomics has raised $50.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2025.
RootPath Genomics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
RootPath Genomics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
RootPath Genomics raised $50.0M in a Series B announced in Sep 2021.
3.6 years later, an undisclosed round was announced in Apr 2025 with no disclosed amount.
RootPath Genomics Founders and Leadership Team
Contact details for the RootPath Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →RootPath Genomics Funding Compared to Other Biotechnology Startups
Funded Startups Like RootPath Genomics in Biotechnology and Cambridge
Companies Similar to RootPath Genomics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
RootPath Genomics Funding FAQs
What does RootPath Genomics do?
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
How much funding has RootPath Genomics raised?
RootPath Genomics has raised $50.0M across 2 rounds on record.
When did RootPath Genomics last raise funding?
RootPath Genomics' most recent funding round on record was announced in Apr 2025. The amount was not disclosed.
Who founded RootPath Genomics?
FundedIQ lists Xi Chen (Founder) at RootPath Genomics.
Where is RootPath Genomics headquartered?
RootPath Genomics is based in Cambridge, Massachusetts, United States.
How many employees does RootPath Genomics have?
RootPath Genomics is in the 11-50 employee band.
About FundedIQ's RootPath Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RootPath Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.